Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	851,971	869,777	176,537	-	-	-
Market Cap Growth	198.82%	392.69%	-	-	-	-
Enterprise Value	794,781	816,363	152,373	-	-	-
Last Close Price	18980.00	19550.00	4085.00	-	-	-
PE Ratio	54.55	55.11	-	-	-	-
PS Ratio	15.96	16.29	11.90	-	-	-
PB Ratio	11.83	12.07	3.15	-	-	-
P/TBV Ratio	11.83	12.07	3.15	-	-	-
P/FCF Ratio	76.81	78.41	-	-	-	-
P/OCF Ratio	74.77	76.33	-	-	-	-
EV/Sales Ratio	14.89	15.29	10.27	-	-	-
EV/EBITDA Ratio	60.45	62.09	-	-	-	-
EV/EBIT Ratio	62.98	64.69	-	-	-	-
EV/FCF Ratio	71.65	73.60	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.01	0.01	-	0.13	-	-
Debt / FCF Ratio	0.01	0.01	-	0.12	-	-
Net Debt / Equity Ratio	-0.73	-0.73	-0.76	5.05	1.24	2.34
Net Debt / EBITDA Ratio	-4.00	-4.00	9.82	-11.05	1.85	2.25
Net Debt / FCF Ratio	-4.74	-4.74	5.35	-9.97	1.56	2.11
Asset Turnover	0.78	0.78	0.30	0.62	0.00	-
Quick Ratio	17.48	17.48	10.61	0.71	1.06	36.08
Current Ratio	17.62	17.62	10.94	0.71	1.06	36.10
Return on Equity (ROE)	24.65%	24.65%	-32.29%	-	-	-
Return on Assets (ROA)	11.55%	11.55%	-6.09%	4.07%	-36.85%	-
Return on Capital Employed (ROCE)	17.50%	17.50%	-8.50%	-39.40%	-343.70%	-44.10%
Earnings Yield	1.85%	1.81%	-4.58%	-	-	-
FCF Yield	1.30%	1.27%	-4.52%	-	-	-
Buyback Yield / Dilution	-38.72%	-38.72%	-41.46%	0.00%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.